Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 34Head and Neck Neoplasms 13Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Melanoma 12Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 11Colonic Neoplasms 10Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Prostatic Neoplasms 7Lymphoma, Follicular 7Breast Neoplasms, Male 7Unspecified Adult Solid Tumor, Protocol Specific 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 6Carcinoma, Ovarian Epithelial 6Ovarian Neoplasms 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Gliosarcoma 5Glioblastoma 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Oligodendroglioma 4Liver Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Kidney Neoplasms 4

Interventions

Cisplatin 115Radiotherapy 83Paclitaxel 77Fluorouracil 61Carboplatin 41Drug Therapy 34pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26Oxaliplatin 23Neoadjuvant Therapy 23toripalimab 22sintilimab 19camrelizumab 19Radiation 19Esophagectomy 17Capecitabine 17130-nm albumin-bound paclitaxel 17Surgical Procedures, Operative 15Leucovorin 15Nivolumab 14Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10anlotinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Esophageal Squamous Cell Carcinoma × Immunohistochemistry × Clear all
NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Wake Forest University Health Sciences

Phase 1 Completed
9 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00524121 2016-04-14

Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
22 enrolled 13 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00397904 2015-11-25

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
16 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡